UK:
Risk And Regulation Monthly - October 2013
26 November 2013
Deloitte
To print this article, all you need is to be registered or login on Mondaq.com.
Background
The Risk and Regulation Monthly provides a summary of the key
International, European and UK regulatory developments and
pertinent regulatory activity affecting the Financial Services
industry.
October was a particularly intensive month for regulatory news.
Highlights included the Fundamental Review of the Trading
Book, and plans to introduce a risk-based global
insurance capital regime internationally, the agreement on
the Single Supervisory Mechanism and the
accompanying asset quality review methodology in
the Eurozone, and details on the supervisory regime for
asset managers in the UK.
As usual this note is produced for information only on a best
efforts basis, and does not constitute advice of any kind.
If you would like to subscribe to Deloitte's Risk and
Regulatory Monthly or would like to receive previous copies please
register here.
Download
Risk and Regulation Monthly October 2013
(PDF)
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Finance and Banking from UK
Asset Recovery Comparative Guide
Bird & Bird
Asset Recovery Comparative Guide for the jurisdiction of UK, check out our comparative guides section to compare across multiple countries
FCA's Consultation Paper
Cadwalader, Wickersham & Taft LLP
Since 3 January 2018, firms that provide portfolio management or investment advice on an independent basis must pay for the research they obtain...
Regulation Round Up
Proskauer Rose LLP
Welcome to the UK Regulation Round Up, a regular bulletin highlighting the latest developments in UK and EU financial services regulation.
FCA To Permit Research Bundling
Akin Gump Strauss Hauer & Feld LLP
The Financial Conduct Authority (FCA) is seeking views on proposed rules that would allow asset managers to opt for bundled payments for third-party investment research, reversing a significant aspect of the UK's implementation of research rules under the Markets in Financial Instruments Directive (MiFID II).